PubMed for id: 324539

Year	Number of Results
1990	1
1991	1
1995	2
2003	1
2004	3
2005	2
2009	1
2024	0

1

Neurologic manifestations of Kanzaki disease.

Umehara F, Matsumuro K, Kurono Y, Arimura K, Osame M, Kanzaki T. Umehara F, et al. Neurology. 2004 May 11;62(9):1604-6. doi: 10.1212/01.wnl.0000123116.96441.34. Neurology. 2004. PMID: 15136691

2

Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease).

Sakuraba H, Matsuzawa F, Aikawa SI, Doi H, Kotani M, Nakada H, Fukushige T, Kanzaki T. Sakuraba H, et al. J Hum Genet. 2004;49(1):1-8. doi: 10.1007/s10038-003-0098-z. Epub 2003 Dec 19. J Hum Genet. 2004. PMID: 14685826

3

[Schindler disease/Kanzaki disease].

Kanzaki T. Kanzaki T. Nihon Rinsho. 1995 Dec;53(12):2982-7. Nihon Rinsho. 1995. PMID: 8577046 Review. Japanese.

4

Histopathologic and ultrastructural studies of angiokeratoma corporis diffusum in Kanzaki disease.

Yokota M, Koji M, Yotsumoto S. Yokota M, et al. J Dermatol. 1995 Jan;22(1):10-8. doi: 10.1111/j.1346-8138.1995.tb03333.x. J Dermatol. 1995. PMID: 7897017

5

Isolation and characterization of major urinary amino acid O-glycosides and a dipeptide O-glycoside from a new lysosomal storage disorder (Kanzaki disease). Excessive excretion of serine- and threonine-linked glycan in the patient urine.

Hirabayashi Y, Matsumoto Y, Matsumoto M, Toida T, Iida N, Matsubara T, Kanzaki T, Yokota M, Ishizuka I. Hirabayashi Y, et al. J Biol Chem. 1990 Jan 25;265(3):1693-701. J Biol Chem. 1990. PMID: 2104850 Free article.

6

Blood group A glycosphingolipid accumulation in the hair of patients with alpha-N-acetylgalactosaminidase deficiency.

Kimura A, Kanekura T, Saito Y, Sagawa K, Nosaka M, Kanzaki T, Tsuji T. Kimura A, et al. Life Sci. 2005 Mar 4;76(16):1817-24. doi: 10.1016/j.lfs.2004.09.027. Epub 2005 Jan 21. Life Sci. 2005. PMID: 15698859

7

Three dimensional structural studies of alpha-N-acetylgalactosaminidase (alpha-NAGA) in alpha-NAGA deficiency (Kanzaki disease): different gene mutations cause peculiar structural changes in alpha-NAGAs resulting in different substrate specificities and clinical phenotypes.

Kanekura T, Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Hirabayashi Y, Yoshii N, Fukushige T, Kanzaki T. Kanekura T, et al. J Dermatol Sci. 2005 Jan;37(1):15-20. doi: 10.1016/j.jdermsci.2004.09.005. Epub 2004 Dec 8. J Dermatol Sci. 2005. PMID: 15619430

8

The 1.9 a structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases.

Clark NE, Garman SC. Clark NE, et al. J Mol Biol. 2009 Oct 23;393(2):435-47. doi: 10.1016/j.jmb.2009.08.021. Epub 2009 Aug 14. J Mol Biol. 2009. PMID: 19683538 Free PMC article.

9

Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria.

Kanzaki T, Wang AM, Desnick RJ. Kanzaki T, et al. J Clin Invest. 1991 Aug;88(2):707-11. doi: 10.1172/JCI115357. J Clin Invest. 1991. PMID: 1907616 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year